Researchers check safety of existing hemophilia drug
NCT ID NCT04682145
Summary
This study is collecting safety information from an existing European patient registry. It aims to monitor side effects in people with hemophilia A who are already being treated with the medication turoctocog alfa pegol. The study does not involve giving patients any new treatment or changing their care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novo Nordisk Investigational Site
Søborg, 2860, Denmark
Conditions
Explore the condition pages connected to this study.